|Articles|July 25, 2022
Calyx and Qynapse Announce Partnership
Partnership to enable AI-enhanced medical imaging services for CNS clinical trials.
Advertisement
Calyx announced it has entered into a partnership with Qynapse. The partnership enables Calyx to adopt and deliver Qynapse's AI-powered neuroimaging analysis solutions, QyScore® and QyPredict® to its global pharmaceutical and biotech customers as they develop new medical treatments for central nervous system (CNS) disorders.
Read more about the partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
3
Integrating Trials into Routine Care
4
When AI Learns to Speak Every Language: An eCOA Migration Study
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
